MedTrace Logo

High Risk Crack Use Settings and HIV in El Salvador

NCT01279421 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4382

Last updated 2021-05-14

No results posted yet for this study

Summary

This project will first increase the accessibility and acceptability of rapid HIV testing in health clinics located in or near four low-income communities in San Salvador, El Salvador. The investigators will use crack users' social networks and small incentives, as recommended by the CDC, in collaboration with the Salvadoran Ministry of Public Health and Social Assistance (MSPAS) to encourage crack users to receive HIV testing. The second part of the intervention consists of training 8 Peer Leaders to recruit and lead a Peer Network Intervention among 400 crack users to change norms supporting HIV protective behaviors. The intervention will include monthly meetings open to crack using and non-crack using community residents to reinforce HIV risk reduction skills, and discussion of other topics related to HIV such as illicit drug use and interpersonal violence and community-wide HIV awareness events. Our hypothesis is that these two intervention features will singly, and in combination, reduce HIV risk behaviors among Salvadoran crack users.

Conditions

  • HIV
  • Sexually Transmitted Diseases

Interventions

BEHAVIORAL

Social Network HIV Testing

Crack users will be recruited for HIV testing and receive 3 coupons to recruit other crack users for HIV testing.

BEHAVIORAL

Peer Network Intervention

Peer leaders will recruit small networks of crack users and facilitate a three-day prevention intervention.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Medical College of Wisconsin

    lead OTHER

Principal Investigators

  • Julia B. Dickson-Gomez, Ph.D. · Medical College of Wisconsin

  • Gloria Bodnar, Ph.D. · Fundacion Antidrogas de El Salvador (FUNDASALVA)

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2016-06-30
Completion
2020-12-31

Countries

  • El Salvador

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01279421 on ClinicalTrials.gov